About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Global Digital Pills Market Size, Top Share, Demand, Report to 2032
Digital Pills Market

Digital Pills Market Size, Share & Trends Analysis Report By Indicated Disorders (Tracking Ingestion in Schizophrenia Patients, Tracking Ingestion in Bipolar Patients, Adjunctive treatment of MDD (major depressive disorder) in adults), By End-Users (Hospitals, Clinic, Home Care Settings) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRHI37DR
Author : Straits Research
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Digital Pills Market Introduction
    2. By Indicated Disorders
      1. Introduction
        1. Indicated Disorders By Value
      2. Tracking Ingestion in Schizophrenia Patients
        1. By Value
      3. Tracking Ingestion in Bipolar Patients
        1. By Value
      4. Adjunctive treatment of MDD (major depressive disorder) in adults
        1. By Value
    3. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Hospitals
        1. By Value
      3. Clinic
        1. By Value
      4. Home Care Settings
        1. By Value
    1. Introduction
    2. By Indicated Disorders
      1. Introduction
        1. Indicated Disorders By Value
      2. Tracking Ingestion in Schizophrenia Patients
        1. By Value
      3. Tracking Ingestion in Bipolar Patients
        1. By Value
      4. Adjunctive treatment of MDD (major depressive disorder) in adults
        1. By Value
    3. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Hospitals
        1. By Value
      3. Clinic
        1. By Value
      4. Home Care Settings
        1. By Value
    4. U.S.
      1. By Indicated Disorders
        1. Introduction
          1. Indicated Disorders By Value
        2. Tracking Ingestion in Schizophrenia Patients
          1. By Value
        3. Tracking Ingestion in Bipolar Patients
          1. By Value
        4. Adjunctive treatment of MDD (major depressive disorder) in adults
          1. By Value
      2. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Hospitals
          1. By Value
        3. Clinic
          1. By Value
        4. Home Care Settings
          1. By Value
    5. Canada
    1. Introduction
    2. By Indicated Disorders
      1. Introduction
        1. Indicated Disorders By Value
      2. Tracking Ingestion in Schizophrenia Patients
        1. By Value
      3. Tracking Ingestion in Bipolar Patients
        1. By Value
      4. Adjunctive treatment of MDD (major depressive disorder) in adults
        1. By Value
    3. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Hospitals
        1. By Value
      3. Clinic
        1. By Value
      4. Home Care Settings
        1. By Value
    4. U.K.
      1. By Indicated Disorders
        1. Introduction
          1. Indicated Disorders By Value
        2. Tracking Ingestion in Schizophrenia Patients
          1. By Value
        3. Tracking Ingestion in Bipolar Patients
          1. By Value
        4. Adjunctive treatment of MDD (major depressive disorder) in adults
          1. By Value
      2. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Hospitals
          1. By Value
        3. Clinic
          1. By Value
        4. Home Care Settings
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europe
    1. Introduction
    2. By Indicated Disorders
      1. Introduction
        1. Indicated Disorders By Value
      2. Tracking Ingestion in Schizophrenia Patients
        1. By Value
      3. Tracking Ingestion in Bipolar Patients
        1. By Value
      4. Adjunctive treatment of MDD (major depressive disorder) in adults
        1. By Value
    3. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Hospitals
        1. By Value
      3. Clinic
        1. By Value
      4. Home Care Settings
        1. By Value
    4. China
      1. By Indicated Disorders
        1. Introduction
          1. Indicated Disorders By Value
        2. Tracking Ingestion in Schizophrenia Patients
          1. By Value
        3. Tracking Ingestion in Bipolar Patients
          1. By Value
        4. Adjunctive treatment of MDD (major depressive disorder) in adults
          1. By Value
      2. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Hospitals
          1. By Value
        3. Clinic
          1. By Value
        4. Home Care Settings
          1. By Value
    5. Korea
    6. Japan
    7. India
    8. Australia
    9. Taiwan
    10. South East Asia
    11. Rest of Asia-Pacific
    1. Introduction
    2. By Indicated Disorders
      1. Introduction
        1. Indicated Disorders By Value
      2. Tracking Ingestion in Schizophrenia Patients
        1. By Value
      3. Tracking Ingestion in Bipolar Patients
        1. By Value
      4. Adjunctive treatment of MDD (major depressive disorder) in adults
        1. By Value
    3. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Hospitals
        1. By Value
      3. Clinic
        1. By Value
      4. Home Care Settings
        1. By Value
    4. UAE
      1. By Indicated Disorders
        1. Introduction
          1. Indicated Disorders By Value
        2. Tracking Ingestion in Schizophrenia Patients
          1. By Value
        3. Tracking Ingestion in Bipolar Patients
          1. By Value
        4. Adjunctive treatment of MDD (major depressive disorder) in adults
          1. By Value
      2. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Hospitals
          1. By Value
        3. Clinic
          1. By Value
        4. Home Care Settings
          1. By Value
    5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest of MEA
    1. Introduction
    2. By Indicated Disorders
      1. Introduction
        1. Indicated Disorders By Value
      2. Tracking Ingestion in Schizophrenia Patients
        1. By Value
      3. Tracking Ingestion in Bipolar Patients
        1. By Value
      4. Adjunctive treatment of MDD (major depressive disorder) in adults
        1. By Value
    3. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Hospitals
        1. By Value
      3. Clinic
        1. By Value
      4. Home Care Settings
        1. By Value
    4. Brazil
      1. By Indicated Disorders
        1. Introduction
          1. Indicated Disorders By Value
        2. Tracking Ingestion in Schizophrenia Patients
          1. By Value
        3. Tracking Ingestion in Bipolar Patients
          1. By Value
        4. Adjunctive treatment of MDD (major depressive disorder) in adults
          1. By Value
      2. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Hospitals
          1. By Value
        3. Clinic
          1. By Value
        4. Home Care Settings
          1. By Value
    5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest of LATAM
    1. Digital Pills Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Proteus Digital Health Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Leaf Healthcare
    3. Intellicap
    4. Perficient Inc.
    5. Microchips Biotech Inc.
    6. Metronic
    7. CapsoVision
    8. Livongo Health
    9. AliveCor Inc.
    10. WellDoc Inc.
    11. Omada Health Inc.
    12. Novartis AG
    13. Abbott
    14. Mocacare
    15. Gentag Inc.
    16. iRhythm Technologies Inc.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Digital Map Market Size The global digital map market size was valued at USD 24.21 billion in 2024 and is projected to reach from USD 27.24 billion in 2025 to USD 69.89 billion by 2033, growing at a CAGR of 12.5% during the forecast period (2025-203
Buy Now
Global Report
Digital Payments Market Size The global digital payments market size was valued at USD 119.40 billion in 2024 and is expected to grow from USD 142.28 billion in 2025 to reach USD 578.33 billion by 2033, growing at a CAGR of&
Buy Now
Global Report
Market Overview The global digital PCR market size is estimated to reach USD 1236 million in size by 2030, growing at a CAGR of 9.3%, from USD 555 million in 2021. The digital polymerase chain reaction (dPCR) is a new method for dete
Buy Now
Global Report
Market OverviewThe global digital twin market was valued at USD 10.42 million in 2022. It is expected to reach USD 204.56 million by 2031, growing at a CAGR of 39.2% during the forecast period (2023–2031). A virtual machine that offers a real-time o
Buy Now
Global Report
The Global Digital Utility Market Size was valued at USD 161.41 billion in 2021 and is projected to reach USD 428.20 billion by 2030 at a CAGR of 11.45% from 2022 to 2030. The utility industry is presented with a transformative opportunity by the ra
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.